Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
ā
of holders' portfolios
13F filers
1
institution
Market cap
$250.0M
18M shares
52-week range
$13.50 ā $32.32
1% from low
Sector
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Exchange
NYSE
CS
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).
www.usana.comNo one on the platform currently holds USNA.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,017,630 | $17.8M |
| Execution date | Ratio |
|---|---|
| 2016-11-22 | 2-for-1 |
| 2003-10-23 | 2-for-1 |
No one on the platform has traded USNA yet.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $910M | -1.6% | $0.76 | $0.76ā$0.76 | 18.0Ć | 1 |
| 2028 | $954M | +4.9% | $1.77 | $1.77ā$1.77 | 7.7Ć | 1 |
Forward consensus Ā· growth is YoY vs the prior fiscal-year estimate Ā· Fwd P/E at the current price Ā· source: Financial Modeling Prep
Beat consensus in 6 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-04 | $0.43 | $-0.07 | -116.3% |
| 2026-05-05 | $0.44 | $0.61 | +38.6% |
| 2026-02-17 | $0.41 | $0.60 | +46.3% |
| 2025-10-21 | $0.25 | $-0.15 | -160.0% |
| 2025-07-22 | $0.54 | $0.74 | +37.0% |
| 2025-04-22 | $0.70 | $0.73 | +4.3% |
| 2025-02-25 | $0.49 | $0.64 | +30.6% |
| 2024-10-22 | $0.49 | $0.56 | +14.3% |
| $507M |
| ā |
| LNDBrasilAgro - Companhia Brasileira de Propriedades AgrĆcolas | $3.58 | +2.58% | $357M | ā |
| LWAYLifeway Foods, Inc. | $24.70 | -15.47% | $377M | ā |
Source: Financial Modeling Prep Ā· peers by sector/industry
New research today on @USANAinc $USNA #sidotiresearch Read note: http://dlvr.it/TTtt3w #investing #smallcap #microcap
View on StockTwits ā$USNA sell-off was overdone here. They have 168m cash, 0 debt and FCF for the quarter was 20m positive. Also insider ownership is 40% and institutional ownership was 55%, be interesting to see what level it's at after yesterday's move down...
View on StockTwits ā$USNA is it oversold? quite a dramatic drop for a cash rich low debt company that has around for years
View on StockTwits ā$USNA A business once seen as a reliable cash machine in health and wellness now faces new doubts about how durable its profits are and how fast it's trying to build out multiple brands. The rest of the earnings shows why the market punished it so hard. š¢ š Possible
View on StockTwits ā$USNA (-20.8% pre) USANA Health Sciences (USNA) Reports Q2 Loss, Lags Revenue Estimates https://ooc.bz/l/110044
View on StockTwits āNew research today on @USANAinc $USNA #sidotiresearch Read note: http://dlvr.it/TTsl94 #investing #smallcap #microcap
View on StockTwits ā$USNA Q2 '26 Earnings Results & Recap ⢠Reported GAAP EPS of -$1.16 down -323.08% YoY ⢠Reported revenue of $223.27M down -5.33% YoY ⢠USANA Health Sciences updated its fiscal year 2026 outlook, now expecting consolidated net sales of $910 million, a net loss of $(11) million, and adjusted diluted EPS of $0.76.
View on StockTwits āWall St is expecting 0.43 EPS for $USNA Q3 [Reporting 10/27 AMC] http://www.estimize.com/intro/usna?chart=historical&metric_name=eps&utm_co
View on StockTwits āNew research on @USANAinc $USNA #sidotiresearch Read note: http://dlvr.it/TTf056 #investing #smallcap #microcap
View on StockTwits ā$USNA Share Price: $17.75 Contract Selected: Jan 15, 2027 $30 Calls Buy Zone: $0.46 ā $0.57 Target Zone: $0.81 ā $0.99 Potential Upside: 67% ROI Time to Expiration: 224 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ā$BODI The Beachbody Company: A Turnaround That Already Bodes Well https://seekingalpha.com/article/4909577-the-beachbody-company-a-turnaround-that-already-bodes-well?utm_source=webull.com&utm_medium=referral&feed_item_type=article $USNA
View on StockTwits āNew research this week on @USANAinc $USNA #sidotiresearch Read note: http://dlvr.it/TSRQJb #investing #smallcap #microcap
View on StockTwits ā$USNA Current Stock Price: $19.46 Contracts to trade: $17.5 USNA May 15 2026 Call Entry: $0.55 Exit: $0.97 ROI: 76% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits āRecent $TICKER stream from stocktwits.com ā refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.